Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials.

Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials.

Item
http://www.wikidata.org/entity/Q38856521
Triplet combinations in relapsed/refractory myeloma: update on recent phase 3 trials.Real-world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi-centre UK experience.Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis.Pomalidomide, bortezomib and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma.Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial.Current and developing synthetic pharmacotherapy for treating relapsed/refractory multiple myeloma.Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy.Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma.Pomalidomide: A Review in Relapsed and Refractory Multiple Myeloma.Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.Pomalidomide in multiple myeloma.
P2860

Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials.

Item
http://www.wikidata.org/entity/Q38856521
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Pomalidomide plus low-dose dex ...... ysis of three clinical trials.
@en
type
label
Pomalidomide plus low-dose dex ...... ysis of three clinical trials.
@en
prefLabel
Pomalidomide plus low-dose dex ...... ysis of three clinical trials.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Pomalidomide plus low-dose dex ...... ysis of three clinical trials.
@en
P2093
P2860
P304
P31
P356
10.1080/10428194.2016.1177181
P433
P478
P50
P577
P698
P921